cv
Basics
Name | Ahmad Abu Turab Naqvi |
Label | Scientist |
Url | https://abuturabnaqvi.github.io/ |
Summary | A bioinformatician, computational biologist, data scientist and poet. |
Work
-
Sep 2016 - Aug 2019 DST SERB Senior Research Fellow
CIRBSc, JMI, New Delhi
As Bioinformatician, I contributed to the in-silico part of the project which dealt with screening and filtering of potential compounds as inhibitors of MARK4 kinase activity. I performed molecular docking and molecular dynamics simulations to design inhibitors against MARK4. I efficiently used chemoinformatics techniques to screen compounds and performed docking (AutoDock Suit) and MD simulations (GROMACS).
- Structural Bioinformatics
Volunteer
-
Jul 2014 - Sep 2016 New Delhi, India
Project Assistant
Jamia Millia Islamia
Structural and Functional Assignment to Hypothetical Proteins from Common Indian Pathogens.
- Functional and Comparative Genomics
Education
-
Jul 2012 - Jun 2014 New Delhi, India
-
Aug 2018 - Oct 2023 New Delhi, India
Certificates
Diploma in French | ||
D/O Foreign Languages, JMI | 2016-07-01 |
Certificate of Proficiency in French | ||
D/O Foreign Languages, JMI | 2015-07-01 |
CCC Certification in Computational Skills | ||
NIELIT, Chandigarh | 2012-01-01 |
Publications
-
2023.01.01 Pan-cancer analysis of Chromobox (CBX) genes for prognostic significance and cancer classification
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease
Identified high expression of Chromobox genes- CBX2, CBX6, and CBX7 in Cholangiocarcinoma through differential expression analysis and reported CBX2 association with breast cancer via activation of the PI3K/AKT pathway and hepatocellular carcinoma via phosphorylation of YAP protein.
-
2022.02.04 How Machine Learning Has Revolutionized the Field of Cancer Informatics?
Springer Nature Singapore
This chapter aims to give the reader a sense of how machine learning has revolutionized cancer research by making mindful use of enormous cancer data being produced all over the globe.
-
2020.10.01 Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease
The present study highlights the genomic, proteomic, pathogenesis, and therapeutic strategies in SARS-CoV-2 infection. We have carried out sequence analysis of potential drug target proteins in SARS-CoV-2 and, compared them with SARS-CoV and MERS viruses.
Skills
Bioinformatics | |
Differential Gene Expression Analysis | |
NGS data analysis | |
Molecular Docking | |
Molecular Dynamics Simulation | |
Nextflow | |
R, Python, Shell |
Languages
Hindi | |
Native speaker |
English | |
Fluent |
References
Professor SAM Rizvi | |
Department of Computer Science, Jamia Millia Islamia, New Delhi |
Professor Md. Imtaiyaz Hassan | |
Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi |